Not medical advice Parkinson's Companion is an educational synthesis of published literature for study, patient understanding and family caregivers. It does not replace a clinician. Doses and guideline statements are reported as published, not as instructions for any individual, and Parkinson's medicines should never be stopped suddenly.
Parkinson's disease: an animated, cited guide
This page needs JavaScript for its animations. The outline and key answers are below, and every claim in the full version carries a numbered citation.
Not medical advice. Parkinson's Companion is an educational synthesis of published literature. It does not replace a clinician.
What is in it
What Parkinson's is Parkinsonism versus Parkinson's disease, who it affects, the numbers.
The dopamine pathway Substantia nigra to striatum, the go and brake loops, and what losing dopamine does.
Alpha-synuclein and Lewy bodies From a small synaptic protein to a Lewy body, and how it may spread.
How it spreads: Braak stages Six stages from the brainstem to the cortex, and the body-first debate.
Genes and inheritance LRRK2, GBA1, SNCA and parkin, founder populations, and what a test means.
Before the tremor Dream enactment, smell, constipation and the prodromal criteria.
Stages and symptoms Hoehn and Yahr, motor and non-motor symptoms, and how fast it moves.
Diagnosis and the MDS criteria The clinical criteria as a calculator, DaT scans and synuclein tests.
The differential Essential tremor, drug-induced parkinsonism, MSA, PSP and Lewy body dementia.
Levodopa and carbidopa From the pill to the striatum, step by step.
Levodopa over time Wearing-off, dyskinesia, the narrowing window and what smooths it.
The other medicines Agonists, MAO-B and COMT inhibitors, amantadine and the order of use.
Deep-brain stimulation Targets, the stimulation field, the beta rhythm and what the trials found.
Beyond movement Mood, hallucinations, dementia, sleep and blood pressure.
Risk and protection Pesticides, solvents, head injury, smoking, coffee and exercise.
Living with Parkinson's Exercise, therapy, falls, speech, work, caregiving and the end of life.
Nursing care Medicines on time, drugs to avoid, swallowing, assessment, documentation.
Toward a cure Synuclein antibodies, GLP-1 drugs, LRRK2 and GBA1, cells and genes.
History and people From James Parkinson's 1817 essay to the synuclein test.
Flashcards and mnemonics Flip cards by topic.
Quiz Questions with explanations.
Glossary Every term, searchable.
Sources Every reference behind the guide.
Part 1 · The disease
The dopamine pathway
Movement depends on a loop that runs from the cortex through the basal ganglia and thalamus and back. Dopamine from a small strip of the midbrain keeps that loop tilted toward "go". Step through the loop, then take the dopamine away and watch the brake win.
Show
Healthy
Parkinson's
Overlay
Where DBS acts
Where drugs act
excitatory (glutamate) inhibitory (GABA) dopamine treatment overlay
The dopamine reserve: how much is gone before symptoms
Symptoms do not start when the first nigral neuron dies. Loss builds silently for years, and the nerve endings in the striatum go faster than the cell bodies in the midbrain. Scrub through the years around diagnosis. The figures come from post-mortem counts and imaging, and they do not all agree. 58,105,178
Add
Other estimates at onset
The old "80%" figure
What the box diagram gets right, and where it breaks